Slager David Mark 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-09 3:52 pm Purchase | 2020-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP | Slager David Mark | 1,344,123 5.040% | 27,800 (+2.11%) | Filing |
| 2020-02-11 11:46 am Sale | 2019-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP | Slager David Mark | 1,316,323 7.400% | -11,293 (-0.85%) | Filing |